113 results  1 of 6 

1 제주 지역의 30년간 염증성 장질환의 동향
Jin Woo Kim, Hyun Joo Song, Sun-Jin Boo, Heung Up Kim, Ki Soo Kang, Soo-Young Na
Korean J Gastroenterol.2023;81(6):243-252.   Published online 2023 June 25     DOI: http://dx.doi.org/10.4166/kjg.2023.006
      
2 Risk Factors for the Occurrence and Severity of Vertebral Fractures in Inflammatory Bowel Disease Patients: A Nationwide Population-Based Cohort Study
Arum Choi, Sung Hoon Jung, Sukil Kim, Jun-Seok Lee
J Korean Med Sci.2023;38(28):e210.  Published online 2023 June 8     DOI: http://dx.doi.org/10.3346/jkms.2023.38.e210
      
3 Improvement of ulcerative colitis control by searching and restricting of inflammatory trigger factors in daily clinical practice
Kun-Yu Tsai, Jeng-Fu You, Tzong-Yun Tsai, Yih Jong Chern, Yu-Jen Hsu, Shu-Huan Huang, Wen-Sy Tsai
Intest Res.2023;21(1):100-109.   Published online 2022 November 14     DOI: http://dx.doi.org/10.5217/ir.2021.00110
      
4 Inflammatory bowel disease (IBD)-disk accurately predicts the daily life burden and parallels disease activity in patients with IBD
Arshdeep Singh, Yogesh Kumar Gupta, Ashvin Singh Dhaliwal, Bhavjeet Kaur Kahlon, Vasu Bansal, Ramit Mahajan, Varun Mehta, Dharmatma Singh, Ramandeep Kaur, Namita Bansal, Vandana Midha, Ajit Sood
Intest Res.2023;21(3):375-384.   Published online 2022 October 18     DOI: http://dx.doi.org/10.5217/ir.2022.00037
      
5 Vedolizumab Is Safe and Efficacious for the Treatment of Pediatric-Onset Inflammatory Bowel Disease Patients Who Fail a Primary Biologic Agent
Sujin Choi, Eun Sil Kim, Yiyoung Kwon, Mi Jin Kim, Yon Ho Choe, Byung-Ho Choe, Ben Kang
J Korean Med Sci.2022;37(37):e282.  Published online 2022 September 14     DOI: http://dx.doi.org/10.3346/jkms.2022.37.e282
      
6 Factors associated with the prescription of probiotics in patients with inflammatory bowel disease: a cross-sectional study
Joo Kyung Kim, Jae Hee Cheon
J Yeungnam Med Sci.2022;40(1):37-48.   Published online 2022 April 18     DOI: http://dx.doi.org/10.12701/jyms.2022.00031
      
7 The Comparative Risk of Serious Adverse Events With Tofacitinib and TNF Inhibitors in Patients With Ulcerative Colitis: The Korean Experience as Revealed by a National Database
Gi Hyeon Seo, Sung Hoon Jung
J Korean Med Sci.2022;37(16):e123.  Published online 2022 April 12     DOI: http://dx.doi.org/10.3346/jkms.2022.37.e123
      
8 Potential Utility of Fecal Calprotectin in Discriminating Colorectal Polyps From Other Major Etiologies in Children Presenting With Isolated Hematochezia
Yu Bin Kim, Ju Young Kim, Sujin Choi, Hyun Jin Kim, Yoo Min Lee, Yoon Lee, Hyo-Jeong Jang, Eun Hye Lee, Kyung Jae Lee, Soon Chul Kim, So Yoon Choi, Yunkoo Kang, Dae Yong Yi, You Jin Choi, Byung-Ho Choe, Ben Kang
J Korean Med Sci.2022;37(9):e72.  Published online 2022 February 28     DOI: http://dx.doi.org/10.3346/jkms.2022.37.e72
      
9 Association of young age and male sex with primary sclerosing cholangitis in Taiwanese patients with inflammatory bowel disease
Meng-Tzu Weng, I-Lun Shih, Chien-Chih Tung, Yew-Loong Leong, Ming-Jium Shieh, Cheng-Yi Wang, Jau-Min Wong, Yen-Hsuan Ni, Shu-Chen Wei
Intest Res.2022;20(2):224-230.   Published online 2022 February 8     DOI: http://dx.doi.org/10.5217/ir.2021.00042
      
10 Clinical Course of COVID-19 in Patients with Inflammatory Bowel Disease in Korea: a KASID Multicenter Study
Jin Wook Lee, Eun Mi Song, Sung-Ae Jung, Sung Hoon Jung, Kwang Woo Kim, Seong-Joon Koh, Hyun Jung Lee, Seung Wook Hong, Jin Hwa Park, Sung Wook Hwang, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Sang Hyoung Park,
J Korean Med Sci.2021;36(48):e336.  Published online 2021 November 24     DOI: http://dx.doi.org/10.3346/jkms.2021.36.e336
      
11 Severe Disease Activity Based on the Paris Classification Is Associated with the Development of Extraintestinal Manifestations in Korean Children and Adolescents with Ulcerative Colitis
Hyo-Jeong Jang, Hyo Rim Suh, Sujin Choi, Suk Jin Hong, Seung-Man Cho, Kwang-Hae Choi, Byung-Ho Choe, Ben Kang,
J Korean Med Sci.2021;36(44):e278.  Published online 2021 October 1     DOI: http://dx.doi.org/10.3346/jkms.2021.36.e278
      
12 Pediatric-onset Inflammatory Bowel Disease: What Are Different from Adult in the Treatment?
Soyoon Choi, Won Moon
Korean J Gastroenterol.2021;77(5):220-226.   Published online 2021 May 25     DOI: http://dx.doi.org/10.4166/kjg.2021.067
      
13 Granulocyte and monocyte apheresis therapy for patients with active ulcerative colitis associated with COVID-19: a case report
Miki Koroku, Teppei Omori, Harutaka Kambayashi, Shun Murasugi, Tomoko Kuriyama, Yuichi Ikarashi, Maria Yonezawa, Ken Arimura, Kazunori Karasawa, Norio Hanafusa, Masatoshi Kawana, Katsutoshi Tokushige
Intest Res.2022;20(1):150-155.   Published online 2021 March 12     DOI: http://dx.doi.org/10.5217/ir.2020.00148
      
14 Risk factors for non-reaching of ileal pouch to the anus in laparoscopic restorative proctocolectomy with handsewn anastomosis for ulcerative colitis
Shigenobu Emoto, Keisuke Hata, Hiroaki Nozawa, Kazushige Kawai, Toshiaki Tanaka, Takeshi Nishikawa, Yasutaka Shuno, Kazuhito Sasaki, Manabu Kaneko, Koji Murono, Yuuki Iida, Hiroaki Ishii, Yuichiro Yokoyama, Hiroyuki Anzai, Hirofumi Sonoda, Soichiro Ishihara
Intest Res.2022;20(3):313-320.   Published online 2021 March 12     DOI: http://dx.doi.org/10.5217/ir.2020.00158
      
15 Vedolizumab does not increase perioperative surgical complications in patients with inflammatory bowel disease, cohort study
Vitaliy Y. Poylin, Jose Cataneo Serrato, Jonathan Pastrana Del Valle, Joseph D. Feuerstein
Intest Res.2022;20(1):72-77.   Published online 2021 February 3     DOI: http://dx.doi.org/10.5217/ir.2020.00117
      
16 Effectiveness of administering zinc acetate hydrate to patients with inflammatory bowel disease and zinc deficiency: a retrospective observational two-center study
Kensuke Sakurai, Shigeru Furukawa, Takehiko Katsurada, Shinsuke Otagiri, Kana Yamanashi, Kazunori Nagashima, Reizo Onishi, Keiji Yagisawa, Haruto Nishimura, Takahiro Ito, Atsuo Maemoto, Naoya Sakamoto
Intest Res.2022;20(1):78-89.   Published online 2021 January 22     DOI: http://dx.doi.org/10.5217/ir.2020.00124
      
17 Clinical presentation of COVID-19 in patients with inflammatory bowel disease: a systematic review and meta-analysis
Anupam K. Singh, Anuraag Jena, Praveen Kumar-M, Daya Krishna Jha, Vishal Sharma
Intest Res.2022;20(1):134-143.   Published online 2021 January 18     DOI: http://dx.doi.org/10.5217/ir.2020.00108
      
18 The dietary practices and beliefs of British South Asian people living with inflammatory bowel disease: a multicenter study from the United Kingdom
Benjamin Crooks, Ravi Misra, Naila Arebi, Klaartje Kok, Matthew J. Brookes, John McLaughlin, Jimmy K. Limdi
Intest Res.2022;20(1):53-63.   Published online 2021 January 6     DOI: http://dx.doi.org/10.5217/ir.2020.00079
      
19 Efficacy and safety of ustekinumab in East Asian patients with moderately to severely active ulcerative colitis: a subpopulation analysis of global phase 3 induction and maintenance studies (UNIFI)
Tadakazu Hisamatsu, Hyo Jong Kim, Satoshi Motoya, Yasuo Suzuki, Yoshifumi Ohnishi, Noriyuki Fujii, Nobuko Matsushima, Richuan Zheng, Colleen W. Marano
Intest Res.2021;19(4):386-397.   Published online 2020 December 1     DOI: http://dx.doi.org/10.5217/ir.2020.00080
      
20 Very early onset inflammatory bowel disease in a South Asian country where inflammatory bowel disease is emerging: a distinct clinical phenotype from later onset disease
Rupa Banerjee, Partha Pal, Zaheer Nabi, Upender Shava, Girish Ganesh, D. Nageshwar Reddy
Intest Res.2021;19(4):398-407.   Published online 2020 November 20     DOI: http://dx.doi.org/10.5217/ir.2020.00107
      

 1 of 6